812 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
22 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
23 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
24 Recruiting Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing
25 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
26 Recruiting Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Conditions: Depression;   Antidepressant Drug Adverse Reaction
Interventions: Drug: SSRI treated group;   Drug: non-SSRI treated group
27 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
28 Completed EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
29 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
30 Completed Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
Conditions: Pregnancy;   Cesarean Delivery;   General Anesthesia
Intervention: Drug: Remifentanil
31 Active, not recruiting Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Condition: Depression
Interventions: Drug: responders;   Drug: non-responders
32 Completed CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Conditions: Psychiatric Disorders;   Neurodevelopmental Disorders
Intervention:
33 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
34 Completed
Has Results
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Conditions: Idiopathic Growth Hormone Deficiency;   Turner Syndrome
Intervention: Other: Blood sampling
35 Enrolling by invitation Pharmacogenomics of Thiazolidinediones
Condition: Type 2 Diabetes
Intervention: Drug: Pioglitazone
36 Completed
Has Results
Pharmacogenomic Evaluation of Antihypertensive Responses
Condition: Hypertension
Interventions: Drug: Hydrochlorothiazide;   Drug: Atenolol
37 Completed
Has Results
Clopidogrel Pharmacogenomics Project
Condition: Disease Susceptibility
Interventions: Drug: clopidogrel 75 mg;   Drug: Clopidogrel 150 mg
38 Completed Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:
39 Completed Pharmacogenetics of b2-Agonists in Asthma.
Condition: Asthma
Interventions: Drug: fluticasone;   Drug: Salmeterol;   Drug: Ipratropium bromide
40 Not yet recruiting Pharmacogenetics of SGLT2 Inhibitors
Conditions: Diabetes Mellitus;   Gout;   Hyperuricemia
Intervention: Drug: Canagliflozin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years